Cargando…

Pharmacotherapy of mild cognitive impairment

Amnestic mild cognitive impairment (MCI) can be considered as a state with a high risk of developing Alzheimer's disease within 5 years, or as a prodromal stage of this condition. Randomized clinical trials comparing the acetylcholinesterase inhibitor donepezil with placebo have shown some symp...

Descripción completa

Detalles Bibliográficos
Autor principal: Gauthier, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181817/
https://www.ncbi.nlm.nih.gov/pubmed/22034396